{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:36:27Z","timestamp":1791153387254,"version":"4.1.0"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Staphylococci that acquire the\n            <jats:italic>mecA<\/jats:italic>\n            gene are usually resistant to \u03b2-lactam antibiotics (methicillin or oxacillin resistance).\n            <jats:italic>mecA<\/jats:italic>\n            encodes a penicillin-binding protein (PBP 2a) that has a reduced affinity for \u03b2-lactams. In some isolates with methicillin or oxacillin resistance, only a small proportion (\u22640.1%) of the population expresses resistance to \u226510 \u03bcg of oxacillin per ml (heterotypic resistance [HeR]), while in other isolates most of the population expresses resistance (homotypic resistance [HoR]). In the present study, growth of\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            or\n            <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n            strains with HeR in concentrations of oxacillin (0.3 to 0.7 \u03bcg\/ml) that produced a fall or a lag in optical density converted the strains from the HeR to the HoR phenotype. The conversion from the HeR to the HoR phenotype appeared to be due to the selection of a highly resistant mutant population, as determined by fluctuation analysis and the failure of populations with HoR to revert to HeR after 60 generations of growth in antibiotic-free media. The frequencies of conversion were as high as 10\n            <jats:sup>\u22123<\/jats:sup>\n            to 10\n            <jats:sup>\u22122<\/jats:sup>\n            . Conversion to HoR required an intact\n            <jats:italic>mecA<\/jats:italic>\n            gene and an increase in the level of\n            <jats:italic>mecA<\/jats:italic>\n            transcription since no highly resistant subpopulation could be selected after growth in oxacillin when\n            <jats:italic>mecA<\/jats:italic>\n            transcription was constitutively repressed or when\n            <jats:italic>mecA<\/jats:italic>\n            had been inactivated. In addition, in both\n            <jats:italic>S. epidermidis<\/jats:italic>\n            and\n            <jats:italic>S. aureus<\/jats:italic>\n            the level of resistance to vancomycin, which also acts directly on the staphylococcal cell wall, was greater among convertants with HoR than their isogenic parents. The conversion of a population from HeR to HoR involves the selection of a mutation(s) that occurs at a high frequency and most likely requires abundant PBP 2a.\n          <\/jats:p>","DOI":"10.1128\/aac.46.1.24-30.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:55:30Z","timestamp":1027763730000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":54,"title":["Conversion of Oxacillin-Resistant Staphylococci from Heterotypic to Homotypic Resistance Expression"],"prefix":"10.1128","volume":"46","author":[{"given":"J. E.","family":"Finan","sequence":"first","affiliation":[{"name":"Departments of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Rosato","sequence":"additional","affiliation":[{"name":"Microbiology\/Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Departments of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ko","sequence":"additional","affiliation":[{"name":"Biostatistics, Medical College of Virginia at Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon L.","family":"Archer","sequence":"additional","affiliation":[{"name":"Departments of Medicine"},{"name":"Microbiology\/Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.447"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.10.2590"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1368-7646(98)80048-4","volume":"1","year":"1998","unstructured":"Berger-Bachi, B., and M. Tschierske. 1998. Role of Fem factors in methicillin resistance. Drug Resist. Updates1:325\u2013335.","journal-title":"Drug Resist. Updates"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.2.342"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.4.424"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.12.1982"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111965"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/BF02389872","volume":"12","year":"1993","unstructured":"de Lencastre, H., A. M. Figueiredo, and A. Tomasz. 1993. Genetic control of population structure in heterogeneous strains of methicillin resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis.12(Suppl. 1):S13\u2013S18.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2590"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1616-1623.2000"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/164.5.883","volume":"164","year":"1991","unstructured":"Figueiredo, A. M., E. Ha, B. N. Kreiswirth, H. de Lencastre, G. J. Noel, L. Senterfit, and A. Tomasz. 1991. In vivo stability of heterogeneous expression classes in clinical isolates of methicillin-resistant staphylococci. J. Infect. Dis.164:883\u2013887.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.1.85"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.11121"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/28.6.491"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.167.3.975-980.1986"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1307"},{"key":"e_1_3_1_18_2","unstructured":"National Committee for Clinical Laboratory Standards. 1993. Approved standard M7\u2013A3. Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.18.5464-5471.1996"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5469.1251"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.724"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1994.tb00416.x"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.180.8.2160-2166.1998"},{"key":"e_1_3_1_24_2","unstructured":"Kendall\u2019s advanced theory of statistics 5th ed. 1991"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.4.769"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.1.124"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.9.1624"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90011-1"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.322276"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.1.24-30.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.1.24-30.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:29:57Z","timestamp":1645464597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.1.24-30.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1128\/AAC.46.1.24-30.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.1.24-30.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"2001-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}